Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research Centre of Marseille (CRCM), shared a post on LinkedIn:
“Honored to contribute to this Meeting Report from the G7 Cancer Conference, now available online: “Poor prognosis cancers: from resignation to revolution.”
This collective work reflects a strong international momentum to better understand and tackle cancers with historically very poor survival, including pancreatic cancer.
It was a real privilege to share discussions and perspectives with outstanding colleagues such as Juan Iovanna, Raul Urrutia, Steven Gallinger, Dieter Saur, Anirban Maitra, Pascal Hammel, Michel Ducreux, Patrick Couvreur, Raphael Rodriguez, Klaus Pantel, Belinda Lee, Claude Chelala, John Neoptolemos, Agnieszka Janowska, Ryuji Hamamoto, Marisa Nishio and many others deeply committed to advancing translational oncology.
From our side at CRCM – Centre de Recherche en Cancérologie de Marseille and Institut Paoli-Calmettes, we contributed insights on the use of AI-assisted transcriptomic predictive tools to better guide treatment strategies in pancreatic cancer and help avoid ineffective therapies.
Progress in poor-prognosis cancers will rely more than ever on international collaboration, shared infrastructures and biologically driven precision medicine approaches.”
Title: Meeting Report G7 Cancer Conference Poor prognosis cancers: from resignation to revolution
Authors: Juan Iovanna, Claude Chelala, Kui Son Choi, Patrick Couvreur, Michel Ducreux, Nelson Dusetti, Steven Gallinger, Ryuji Hamamoto, Pascal Hammel, Agnieszka Janowska, Belinda Lee, Anirban Maitra, John Neoptolemos, Marisa Nishio, Klaus Pantel, Hilary Robbins, Raphael Rodriguez, Dieter Saur, Raul Urrutia, Marie Charlotte Henrion, Tomohiro Matsuda, Jérôme Viguier, Bruno Quesnel.
Other articles featuring Nelson Dusetti on OncoDaily.